Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances
Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances
DUBLIN, Jan. 10, 2024 /PRNewswire/ -- The "Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024" report has been added to ResearchAndMarkets.com's offering.
都柏林,2024年1月10日 /PRNewswire/ — “全球脐带血和组织银行行业报告——2024年市场规模、细分和预测” 报告已添加到 ResearchandMarkets.co 提供。
Industry Analysis Unveils Consolidation Dynamics and Regional Market Expansion
行业分析揭示了整合动态和区域市场扩张
The global cord blood and tissue banking industry is undergoing a period of significant transformation characterized by robust merger and acquisition activities, technological innovation, and market expansion.
全球脐带血和组织储存行业正在经历重大变革时期,其特征是强劲的并购活动、技术创新和市场扩张。
A new research publication delves into the intricacies of this dynamic market, offering in-depth insights into current trends, future projections, and strategic developments through 2030.
一本新的研究出版物深入探讨了这个充满活力的市场的复杂性,对当前趋势、未来预测和到2030年的战略发展提供了深入的见解。
Amidst the spotlight on the healthcare sector for tailored and advanced therapeutic solutions, cord blood and tissue banking has emerged as a pivotal component. Cord blood, known for its potent hematopoietic stem cells, has a track record of over 40,000 transplants worldwide, heralding a new era in treatment options for a myriad of diseases.
在医疗保健行业聚焦量身定制和先进的治疗解决方案的背景下,脐带血和组织储存已成为关键组成部分。脐带血以其强大的造血干细胞而闻名,在全球有超过40,000例移植记录,这预示着众多疾病的治疗选择进入了一个新时代。
This comprehensive analysis not only highlights the milestones achieved in cord blood and tissue transplants but also sheds light on the storage capabilities of both public and private banks worldwide.
这项全面的分析不仅重点介绍了在脐带血和组织移植方面取得的里程碑,还揭示了全球公共和私人银行的存储能力。
Strategic Developments and Market Segmentation
战略发展和市场细分
- Public and private cord blood banks' cryopreservation units
- Global utilization of cord blood cells in regenerative medicine
- Emerging technologies enhancing public banks' financial sustainability
- Expansion services in the realm of cord blood banking
- 公共和私人脐带血库的冷冻保存单位
- 脐带血细胞在再生医学中的全球应用
- 新兴技术增强了公共银行的财务可持续性
- 脐带血储备领域的扩展服务
Highlighting the geographical market expanse, the report underscores India's and China's dominant positions, collectively housing over a third of the world's population. Such demographics present vast opportunities for cord blood and tissue banking services. LifeCell International's commanding presence in India, managing over 320,000 stem cell units, exemplifies the regional market's potential.
该报告强调了广阔的地域市场,强调了印度和中国的主导地位,它们共同居住着世界三分之一以上的人口。此类人口结构为脐带血和组织银行服务提供了巨大的机会。LifeCell International在印度占据主导地位,管理着超过32万个干细胞单位,这体现了该地区市场的潜力。
The U.S landscape has not been left behind in the wave of industry consolidation, with major players like CooperSurgical and Cryoholdco cementing their status through strategic acquisitions. With a focus on enhancing comprehensive cord blood banking services, the industry is witnessing expanded offerings that include reproductive services, genetic testing, and cell therapy product development.
在行业整合浪潮中,美国的格局并没有被抛在后面,CooperSurgical和Cryoholdco等主要参与者通过战略收购巩固了其地位。该行业专注于增强全面的脐带血库服务,其产品范围正在扩大,其中包括生殖服务、基因检测和细胞疗法产品开发。
Furthermore, the report identifies the burgeoning market segments within the cord blood and tissue banking sphere, from storage market revenues and the therapeutic use of cord blood in transplantation medicine to the cutting-edge arena of regenerative medicine applications.
此外,该报告还确定了脐带血和组织储存领域新兴的细分市场,从存储市场收入和脐带血在移植医学中的治疗用途到再生医学应用的尖端领域。
Celebrating Scientific Progress and Market Evolution
庆祝科学进步和市场演变
In a market ripe with scientific innovation, such as the groundbreaking FDA approval of Omisirge for recuperating cancer patients' white blood cells, the industry's potential is unmistakable. Moreover, the diverse application in clinical trials, with over 1,200 studies, illustrates the industry's pivotal role in advancing healthcare.
在科学创新成熟的市场中,例如美国食品药品管理局开创性地批准Omisirge用于恢复癌症患者的白细胞,该行业的潜力是显而易见的。此外,超过1,200项研究在临床试验中的多样化应用说明了该行业在促进医疗保健方面的关键作用。
The strategic report is an indispensable resource for stakeholders looking to navigate the complexities of the cord blood and tissue banking industry. It stands as a testament to the ongoing metamorphosis of this niche yet essential healthcare service, offering a horizon of opportunities for market participants and recipients alike.
对于希望了解脐带血和组织银行行业复杂性的利益相关者来说,该战略报告是不可或缺的资源。它证明了这种利基但必不可少的医疗保健服务的持续变革,为市场参与者和接受者提供了机会。
Advocating for informed decision-making and strategic positioning within the healthcare sector, this publication is an authoritative guide that equips entities with the knowledge to leverage the unfolding trends and optimize their operational footprint in the cord blood and tissue banking markets.
该出版物是一份权威指南,倡导在医疗保健领域做出明智的决策和战略定位,为各实体提供了利用正在发生的趋势并优化其在脐带血和组织银行市场的运营足迹的知识。
As the industry continues to evolve, the insights from this report pave the way for informed dialogue, strategic planning, and competitive positioning within the global cord blood and tissue banking landscape.
随着行业的持续发展,这份报告中的见解为全球脐带血和组织储存领域的知情对话、战略规划和竞争定位铺平了道路。
The report presents findings on the following topics:
该报告介绍了有关以下主题的调查结果:
- Number of cord blood and tissue units cryopreserved in public and private cord blood banks worldwide
- Number of hematopoietic stem cell transplants (HSCTs) performed globally using cord blood cells
- Utilization of cord blood cells in regenerative medicine clinical trials
- The decline of the utilization of cord blood cells in HSCT since 2005
- Emerging technologies that will influence the financial sustainability of public cord blood banks
- The future scope for companion products derived from cord blood
- The changing landscape of the cord blood and tissue banking market
- Expansion and extension of services by cord blood banks
- Types of cord blood banks
- Economic model of public cord blood banks
- Cost analysis for public cord blood banks
- Economic model of private cord blood banks
- Cost analysis for private cord blood banks
- Profit margins for private cord blood banks
- Pricing for processing and storage in private banks
- Rate per cord blood unit in the U.S. and Europe
- Indications for the use of cord blood-derived HSCs within transplantation medicine
- Diseases targeted by cord blood-derived MSCs in regenerative medicine
- Cord blood processing technologies
- Number of clinical trials, number of published scientific papers, and amount of NIH funding for cord blood research
- Number and types of patents for cord blood, cord tissue, and placental products
- Transplantation data from different cord blood registries
- 全球公共和私人脐带血库冷冻保存的脐带血和组织单位的数量
- 全球使用脐带血细胞进行的造血干细胞移植 (HSCT) 数量
- 脐带血细胞在再生医学临床试验中的应用
- 自2005年以来,脐带血细胞在造血干细胞中的利用率下降
- 将影响公共脐带血库财务可持续性的新兴技术
- 源自脐带血的配套产品的未来范围
- 脐带血和组织银行市场格局的变化
- 通过脐带血库扩大和扩展服务
- 脐带血库的类型
- 公共脐带血库的经济模型
- 公共脐带血库的成本分析
- 私人脐带血库的经济模式
- 私人脐带血库的成本分析
- 私人脐带血库的利润率
- 私人银行处理和存储的定价
- 美国和欧洲每脐带血单位的比率
- 在移植药物中使用脐带血衍生的造血干细胞的适应症
- 再生医学中脐带血衍生间充质干细胞靶向的疾病
- 脐带血处理技术
- 临床试验数量、发表的科学论文数量以及美国国立卫生研究院对脐带血研究的资助金额
- 脐带血、脐带组织和胎盘产品的专利数量和类型
- 来自不同脐带血登记处的移植数据
Companies Mentioned
提及的公司
- AllCells
- AlphaCord
- Americord Registry, Inc.
- Angiocrine Bioscience
- Anja Health Personalized Cord Blood Banking
- Anthony Nolan
- Baylx, Inc.
- Be The Match
- Biocell Center
- BioEden
- BioIntegrate, LLC
- Bloodworks Northwest
- California Umbilical Cord Collection Program
- Carolinas Cord Blood Bank (CCBB)
- Celaid Therapeutics
- Celebration Stem Cell Centre (CSCC)
- Cell Care
- Cellenkos, Inc.
- Cells4Life Group LLP
- CellSave Arabia
- Celularity, Inc.
- Center for International Blood and Marrow Transplant Research (CIBMTR)
- CHOC Blood Bank
- Cleveland Cord Blood Center
- ClinImmune Cell and Gene Therapy
- CooperSurgical
- Cord Blood Bank of Arkansas (CBBA)
- Cord Blood Center Group
- Cord Blood Registry (owned by CooperSurgical)
- Cord for Life
- CordLife Group, Ltd.
- CordVida
- Crioestaminal
- Cryo-Cell International, Inc.
- CryoCyte, LLC
- Cryoholdco
- Cryolife
- Cryopoint
- Cryoviva Biotech Pvt., Ltd.
- DentCell
- DKMS gGMBH
- Duke University School of Medicine
- European Society for Blood and Bone Marrow Transplantation (EBMT)
- Ever Supreme Bio Technology, Co., Ltd.
- ExCellThera
- FamiCord Group
- Fate Therapeutics, Inc.
- Future Health
- Gamida Cell
- GeneCell
- Global Cord Blood Corporation (GCBC)
- Glycostem Therapeutics
- Hawaii Cord Blood Bank
- HealthBaby
- HealthBanks Biotech Company Ltd.
- HealthBanksUSA
- HEMAFUND
- Hemogenyx Pharmaceuticals
- IMMUNIQUE
- Insception LifeBank
- JP McCarthy Cord Stem Cell Bank
- Kangstem Biotech, Co., Ltd.
- Life Line Stem Cell
- LifebankUSA
- LifeCell International Pvt. Ltd.
- LifeSouth Cord Blood Bank
- Magenta Therapeutics
- Maze Cord Blood
- MD Anderson Cord Blood Bank
- Medipost, Co., Ltd.
- Mesoblast, Ltd.
- MiracleCord, Inc.
- Mononuclear Therapeutics, Ltd.
- New England Cord Blood Bank, Inc.
- New York Blood Center
- OrganaBio
- PacifiCord
- PBKM FamiCord
- Plasticell Ltd.
- ReeLabs Pvt. Ltd.
- Restem, LLC
- San Diego Cord Blood Bank
- Saneron CCEL Therapeutics, Inc.
- Sanpower Group
- SmartCells
- SSM Cardinal Glennon Children's Medical Center
- Stem Cell Cryobank, Inc.
- Stembanc, Inc.
- StemCyte, Inc.
- Throne Biotechnologies, Inc.
- Transcell Biolife
- Upstate Cord Blood Bank
- VCANBIO Cell & Gene Engineering Corporation
- Versity, Inc.
- ViaCord
- Vita 34 AG
- Vitalant Clinical Services
- World Marrow Donor Association (WMDA)
- Worldwide Network for Blood & Marrow Transplantation (WBMT)
- 所有细胞
- AlphaCord
- Americord 注册管理有限公司
- 血管分泌生物科学
- Anja Health 个性化脐带血库
- 安东尼诺兰
- Baylx, Inc.
- 成为对手
- 生物细胞中心
- 生物伊登
- 生物整合有限责任公司
- 西北血厂
- 加州脐带收集计划
- 卡罗来纳州脐带血库 (CCBB)
- Celaid 疗法
- 庆典干细胞中心 (CSCC)
- 细胞护理
- Cellenkos, Inc.
- Cells4Life 集团有限责任公司
- CellSave 阿拉伯
- Celularity, Inc.
- 国际血液与骨髓移植研究中心 (CIBMTR)
- CHOC 血库
- 克利夫兰脐带血中心
- 临床免疫细胞和基因疗法
- 库珀外科
- 阿肯色州脐带血库 (CBBA)
- 脐带血中心小组
- 脐带血登记处(归CooperSurgical所有)
- 生命之绳
- CordLife集团有限公司
- CordVida
- Crioestaminal
- Cryo-Cell 国际有限公司
- CryOcyte 有限责任公司
- cryoholdco
- Cryolife
- Cryopoint
- Cryoviva Biotech Pvt., Ltd.
- DentCell
- DKMS ggmbH
- 杜克大学医学院
- 欧洲血液和骨髓移植学会 (EBMT)
- 永至尊生物科技股份有限公司
- ExcellThera
- FamiCord 集团
- Fate Therapeutics,
- 未来健康
- Gamida Cell
- GeneCell
- 全球脐带血公司 (GCBC)
- 糖干疗法
- 夏威夷脐带血库
- 健康宝贝
- 健康银行生物技术有限公司
- 美国健康银行
- HEMAFUND
- Hemogenyx 制药
- 免疫力
- 失败 LifeBank
- JP 麦卡锡脐带干细胞库
- 康斯坦生物技术有限公司
- 生命线干细胞
- LifeBank美国
- LifeCell 国际私人有限公司
- LifeSouth 脐带血库
- 洋红色疗法
- 迷宫脐带血
- 医学博士安德森脐带血库
- Medipost有限公司
- Mesoblast, Ltd.
- MiracleCord, Inc.
- 单核疗法有限公司
- 新英格兰脐带血库有限公司
- 纽约血液中心
- OrganaBio
- PacifiCord
- PBKM FamiCord
- Plasticell 有限公司
- ReeLabs 私人有限公司
- Restem, LLC
- 圣地亚哥脐带血库
- Saneron CCEL Therapeutics, Inc.
- 三能集团
- 智能细胞
- SSM 红衣主教格伦农儿童医疗中心
- 干细胞低温库有限公司
- Stembanc, Inc.
- StemCyte, Inc.
- Throne 生物技术有限公司
- Transcell Biolife
- 上州脐带血库
- VCANBIO 细胞与基因工程公司
- Versity, Inc.
- ViaCord
- Vita 34 AG
- Vitalant 临床服务
- 世界骨髓捐赠者协会(WMDA)
- 全球血液和骨髓移植网络 (WBMT)
For more information about this report visit
有关此报告的更多信息,请访问
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
关于 ResearchandMarkets
ResearchandMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶级公司、新产品和最新趋势的最新数据。
Media Contact:
媒体联系人:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
研究与市场
劳拉·伍德,高级经理
[电子邮件保护]
如需了解欧洲安全局的办公时间,请致电 +1-917-300-0470
如需美国/加拿大免费电话,请致电 +1-800-526-8630
如需了解格林尼治标准时间办公时间,请致电 +353-1-416-8900
美国传真:646-607-1907
传真(美国境外):+353-1-481-1716
Logo:
徽标:
SOURCE Research and Markets
来源:研究与市场